Health Italia Toekomstige groei
Future criteriumcontroles 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Health Italia.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
Healthcare winstgroei | 21.5% |
Inkomstengroei | n/a |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | None |
Laatst bijgewerkt | n/a |
Recente toekomstige groei-updates
Geen updates
Recent updates
Subdued Growth No Barrier To Health Italia S.p.A. (BIT:HI) With Shares Advancing 35%
Oct 10Investors Can Find Comfort In Health Italia's (BIT:HI) Earnings Quality
Sep 29Returns Are Gaining Momentum At Health Italia (BIT:HI)
Jul 22Health Italia's (BIT:HI) Soft Earnings Don't Show The Whole Picture
Mar 17Lacklustre Performance Is Driving Health Italia S.p.A.'s (BIT:HI) Low P/E
Jan 25Returns Are Gaining Momentum At Health Italia (BIT:HI)
Nov 25Health Italia (BIT:HI) Has A Pretty Healthy Balance Sheet
Oct 21Health Italia (BIT:HI) Shareholders Will Want The ROCE Trajectory To Continue
Aug 07These 4 Measures Indicate That Health Italia (BIT:HI) Is Using Debt Reasonably Well
May 13Returns On Capital At Health Italia (BIT:HI) Have Stalled
Dec 30Here's Why Health Italia (BIT:HI) Can Manage Its Debt Responsibly
Nov 10Be Wary Of Health Italia (BIT:HI) And Its Returns On Capital
Jun 23We Think Health Italia (BIT:HI) Can Stay On Top Of Its Debt
May 27Investors Could Be Concerned With Health Italia's (BIT:HI) Returns On Capital
Feb 23Health Italia (BIT:HI) Seems To Use Debt Quite Sensibly
Dec 08Health Italia (BIT:HI) Will Want To Turn Around Its Return Trends
Oct 06Health Italia (BIT:HI) Will Will Want To Turn Around Its Return Trends
Mar 22Is Health Italia S.p.A. (BIT:HI) A Good Dividend Stock?
Jan 28We're Watching These Trends At Health Italia (BIT:HI)
Dec 04In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Health Italia onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.
Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.
Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
6/30/2024 | 37 | 2 | -11 | 4 | N/A |
3/31/2024 | 37 | 2 | -10 | 3 | N/A |
12/31/2023 | 36 | 2 | -10 | 2 | N/A |
9/30/2023 | 38 | 2 | -3 | 3 | N/A |
6/30/2023 | 39 | 3 | 3 | 3 | N/A |
3/31/2023 | 41 | 3 | 1 | 3 | N/A |
12/31/2022 | 43 | 4 | -2 | 2 | N/A |
9/30/2022 | 43 | 4 | -2 | 3 | N/A |
6/30/2022 | 44 | 3 | -2 | 3 | N/A |
3/31/2022 | 42 | 2 | -1 | 2 | N/A |
12/31/2021 | 41 | 1 | -1 | 1 | N/A |
9/30/2021 | 39 | 2 | 0 | 1 | N/A |
6/30/2021 | 37 | 2 | 1 | 2 | N/A |
3/31/2021 | 35 | 2 | 1 | 1 | N/A |
12/31/2020 | 33 | 2 | 0 | 0 | N/A |
9/30/2020 | 33 | 0 | N/A | N/A | N/A |
6/30/2020 | 32 | -2 | 0 | 6 | N/A |
3/31/2020 | 32 | 0 | 1 | 8 | N/A |
12/31/2019 | 32 | 2 | 2 | 10 | N/A |
9/30/2019 | 30 | 2 | N/A | N/A | N/A |
6/30/2019 | 28 | 3 | -3 | -1 | N/A |
3/31/2019 | 28 | 2 | 0 | 3 | N/A |
12/31/2018 | 27 | 1 | 4 | 7 | N/A |
9/30/2018 | 27 | 0 | -5 | 2 | N/A |
6/30/2018 | 26 | -1 | -14 | -3 | N/A |
3/31/2018 | 24 | -1 | N/A | -3 | N/A |
12/31/2017 | 23 | -1 | N/A | -3 | N/A |
9/30/2017 | 22 | 0 | N/A | N/A | N/A |
6/30/2017 | 21 | 2 | N/A | N/A | N/A |
3/31/2017 | 20 | 2 | N/A | N/A | N/A |
12/31/2016 | 18 | 2 | N/A | 0 | N/A |
12/31/2015 | 13 | 0 | N/A | N/A | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if HI's forecast earnings growth is above the savings rate (2.4%).
Winst versus markt: Insufficient data to determine if HI's earnings are forecast to grow faster than the Italian market
Hoge groeiwinsten: Insufficient data to determine if HI's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: Insufficient data to determine if HI's revenue is forecast to grow faster than the Italian market.
Hoge groei-inkomsten: Insufficient data to determine if HI's revenue is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if HI's Return on Equity is forecast to be high in 3 years time